• ClipSaver
ClipSaver
Русские видео
  • Смешные видео
  • Приколы
  • Обзоры
  • Новости
  • Тесты
  • Спорт
  • Любовь
  • Музыка
  • Разное
Сейчас в тренде
  • Фейгин лайф
  • Три кота
  • Самвел адамян
  • А4 ютуб
  • скачать бит
  • гитара с нуля
Иностранные видео
  • Funny Babies
  • Funny Sports
  • Funny Animals
  • Funny Pranks
  • Funny Magic
  • Funny Vines
  • Funny Virals
  • Funny K-Pop

High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells скачать в хорошем качестве

High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells 6 years ago

High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells

amFAR

CFAR

Judd F. Hultquist

DNA

PACE

Credits

pathogenesis

RNAs

CRISPR-Cas9

University of California

San Francisco

Northwestern University

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells
  • Поделиться ВК
  • Поделиться в ОК
  •  
  •  


Скачать видео с ютуб по ссылке или смотреть без блокировок на сайте: High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells в качестве 4k

У нас вы можете посмотреть бесплатно High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:

  • Информация по загрузке:

Скачать mp3 с ютуба отдельным файлом. Бесплатный рингтон High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells в формате MP3:


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса ClipSaver.ru



High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells

Presented By: Judd F. Hultquist, PhD - Assistant Professor of Medicine, Northwestern University Speaker Biography: Judd F. Hultquist, Ph.D., is an Assistant Professor of Medicine at Northwestern University in Chicago, Illinois. His lab specializes in the adaptation of proteomic and functional genomic technologies to primary models of disease to better understand the molecular dynamics of the host-pathogen relationship. His work on CRISPR technologies with Dr. Nevan Krogan at the University of California, San Francisco led to the development of the first gene editing platform for primary CD4+ T cells, the identification of several novel pathways that contribute to HIV replication, and the discovery of a new class of CRISPR inhibitors encoded by bacteriophages that maintain their function in mammalian cells. He is currently funded by the Third Coast Center for AIDS Research (CFAR) and the American Foundation for AIDS Research (amFAR) to apply CRISPR-Cas9 RNP technology to uncover the molecular mechanisms that underlie HIV latency and reactivation in patient reservoirs. Webinar: High-throughput CRISPR-Cas9 Genome Engineering in Primary T Cells Webinar Abstract: CRISPR-Cas9 gene editing strategies have revolutionized our ability to engineer the genomes of diverse cell types and species for the robust functional interrogation of complex biological processes. Gene editing in primary T-cells represents an important research tool for the development of T-cell based immunotherapies, the study of the autoimmunity, the understanding of host-pathogen dynamics that drive HIV replication and latency, and creation of chimeric antigen receptor (CAR) T cells for the treatment of various cancers. While these cells have proven resistant to traditional transfection and transduction approaches for the CRISPR-Cas9 gene editing, recent advancements in ribonucleoprotein (RNP) delivery have allowed for efficient primary T-cell editing for the first time. In this webinar, we will present a workflow for the design and delivery of CRISPR-Cas9 RNPs to primary, human T-cells by electroporation. This platform supports the high-throughput, arrayed generation of hundreds of specific gene manipulations in only a few hours time without the use of recombinant DNA or lentiviruses and without the need for selection markers. This approach is widely adaptable to an array of downstream applications and protocols for the study of diverse T-cell processes. In this webinar, you will learn: -Optimal conditions for CRISPR-Cas9 gene editing in primary T cells using RNPs -Rules for designing, synthesizing, and validating efficient guide RNAs -Considerations for high-throughput functional screening -How this approach is being employed to better understand HIV replication and pathogenesis Earn PACE Credits: 1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/ms/webinar/h...) 2. Watch the webinar on YouTube or on the LabRoots Website (https://www.labroots.com/ms/webinar/h...) 3. Click Here to get your PACE credits (Expiration date – August 13, 2020 12:00 AM): https://www.labroots.com/credit/pace-... LabRoots on Social: Facebook:   / labrootsinc   Twitter:   / labroots   LinkedIn:   / labroots   Instagram:   / labrootsinc   Pinterest:   / labroots   SnapChat: labroots_inc

Comments
  • Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function 5 years ago
    Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
    Опубликовано: 5 years ago
    4914
  • A Workflow for Knock-in Genome Editing: Simplified 5 years ago
    A Workflow for Knock-in Genome Editing: Simplified
    Опубликовано: 5 years ago
    17982
  • Antibiotics: Cell Wall Synthesis Inhibitors: Part 1 8 years ago
    Antibiotics: Cell Wall Synthesis Inhibitors: Part 1
    Опубликовано: 8 years ago
    588830
  • Introduction to the immune system 1 year ago
    Introduction to the immune system
    Опубликовано: 1 year ago
    304400
  • The Age of CRISPR: Engineering the Future of Genetic Medicine | Benjamin Oakes | TEDxBerkeley 1 year ago
    The Age of CRISPR: Engineering the Future of Genetic Medicine | Benjamin Oakes | TEDxBerkeley
    Опубликовано: 1 year ago
    19932
  • HIV Medications/Drugs 4 years ago
    HIV Medications/Drugs
    Опубликовано: 4 years ago
    308325
  • E.W. Meijer, 4 years ago
    E.W. Meijer, "Functional Supramolecular Systems and Materials"
    Опубликовано: 4 years ago
    4557
  • Signal Transduction Pathways (G-Protein, Receptor Tyrosine Kinase, cGMP) 4 years ago
    Signal Transduction Pathways (G-Protein, Receptor Tyrosine Kinase, cGMP)
    Опубликовано: 4 years ago
    608316
  • How CRISPR lets us edit our DNA | Jennifer Doudna 9 years ago
    How CRISPR lets us edit our DNA | Jennifer Doudna
    Опубликовано: 9 years ago
    1866411
  • Understanding CRISPR-Cas9 3 years ago
    Understanding CRISPR-Cas9
    Опубликовано: 3 years ago
    238647

Контактный email для правообладателей: [email protected] © 2017 - 2025

Отказ от ответственности - Disclaimer Правообладателям - DMCA Условия использования сайта - TOS



Карта сайта 1 Карта сайта 2 Карта сайта 3 Карта сайта 4 Карта сайта 5